{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:03:15Z","timestamp":1788624195493,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the preventive efficacy of human umbilical cord-derived mesenchymal stem cells (hucMSCs)\/Bio-Oss granules composite in a rat model of medication-related osteonecrosis of the jaw (MRONJ).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Twenty-four rats were randomly allocated into a negative control group, a model control group, a Bio-Oss granules group, and a composite group (n = 6). All groups except the negative control group received intraperitoneal injections of zoledronic acid (0.1\u00a0mg\/kg) 3 times per week for 12 weeks to induce MRONJ-like lesions. After 4 weeks of drug administration, standardized bone defects were prepared at the mandibular molar extraction sites. In the negative control and model control groups, the defects were left unfilled. In the Bio-Oss granules and composite groups, the defects were filled with Bio-Oss granules or hucMSCs\/Bio-Oss granules composite, respectively. All rats were euthanized 8 weeks after surgery. Macroscopic observation, micro-CT evaluation, and histological analysis were conducted to assess bone exposure rate, bone volume fraction (BV\/TV), bone mineral density (BMD), and the percentage of empty osteocyte lacunae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The bone exposure rate was 0% in both the negative control and composite groups, compared with 83.33% and 66.67% in the model control and Bio-Oss granules groups, respectively. The composite group showed improved mucosal coverage, as well as significantly higher BV\/TV and BMD and fewer empty osteocyte lacunae than the other bisphosphonate (BP)-treated groups (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Bio-Oss granules alone showed limited efficacy in preventing MRONJ. In contrast, the hucMSCs\/Bio-Oss granules composite effectively promoted mucosal healing and bone regeneration, thereby preventing the development of MRONJ in BP-treated rats.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fbioe.2026.1800764","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:41:39Z","timestamp":1777009299000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Human umbilical cord-derived mesenchymal stem cells\/Bio-Oss granules composite prevents medication-related osteonecrosis of the jaw in a rat model"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhi","family":"Chen","sequence":"first","affiliation":[{"name":"School\/Hospital of Stomatology, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Ningbo Dental Hospital\/Ningbo Oral Health Research Institute","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keying","family":"Shi","sequence":"additional","affiliation":[{"name":"School\/Hospital of Stomatology, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Ningbo Dental Hospital\/Ningbo Oral Health Research Institute","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letian","family":"Shan","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[{"name":"School\/Hospital of Stomatology, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Guo","sequence":"additional","affiliation":[{"name":"Yichen Biotechnology Co., Ltd","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Wang","sequence":"additional","affiliation":[{"name":"School\/Hospital of Stomatology, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"He","sequence":"additional","affiliation":[{"name":"School\/Hospital of Stomatology, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanna","family":"Zheng","sequence":"additional","affiliation":[{"name":"School\/Hospital of Stomatology, Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Ningbo Dental Hospital\/Ningbo Oral Health Research Institute","place":["Ningbo, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3892\/ijmm.2012.952","article-title":"Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells","volume":"29","author":"Abe","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000313787","article-title":"Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws","volume":"124","author":"Allegra","year":"2010","journal-title":"Acta Haematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.3390\/ma12203412","article-title":"Comparison of bone regeneration between porcine-derived and bovine-derived xenografts in rat calvarial defects: a non-inferiority study","volume":"12","author":"Bae","year":"2019","journal-title":"Mater. (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1182\/blood-2007-03-078774","article-title":"Immunogenicity of umbilical cord tissue derived cells","volume":"111","author":"Cho","year":"2007","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1428240","DOI":"10.3389\/fendo.2024.1428240","article-title":"Do NSAIDs affect bone healing rate, delay union, or cause non-union: an updated systematic review and meta-analysis","volume":"15","author":"Chuang","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e929684","DOI":"10.12659\/MSM.929684","article-title":"Exosomes from adipose-derived stem cells can prevent medication-related osteonecrosis of the jaw","volume":"27","author":"Dong","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"B9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s13287-022-03147-w","article-title":"Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis","volume":"13","author":"Feng","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/0022034517691507","article-title":"Role of bone marrow stromal cells in impaired bone repair from BRONJ osseous lesions","volume":"96","author":"He","year":"2017","journal-title":"J. Dent. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18999\/nagjms.82.1.1","article-title":"Iatrogenic risk of osteonecrosis of the jaw? Bone substitutes for dental implants: a warning from Japan","volume":"82","author":"Hibi","year":"2020","journal-title":"Nagoya J. Med. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1089\/scd.2009.0485","article-title":"Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton\u2019s jelly of umbilical cord","volume":"19","author":"Hsieh","year":"2010","journal-title":"Stem Cells Dev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"873814","DOI":"10.3389\/fbioe.2022.873814","article-title":"Stem cell fate and immunomodulation promote bone regeneration via composite Bio-Oss\u00ae\/AviteneTM biomaterial","volume":"10","author":"Iaquinta","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1600-0501.2005.01257.x","article-title":"Bone healing and graft resorption of autograft, anorganic bovine bone and beta-tricalcium phosphate. A histologic and histomorphometric study in the mandibles of minipigs","volume":"17","author":"Jensen","year":"2006","journal-title":"Clin. Oral Implants Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00204-023-03653-7","article-title":"Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies","volume":"98","author":"Jiang","year":"2023","journal-title":"Arch. Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.22203\/eCM.v041a03","article-title":"Cell therapy for medication-related osteonecrosis of the jaw: update on treatment strategies","volume":"41","author":"Kaibuchi","year":"2021","journal-title":"Eur. Cell Mater."},{"key":"B17","doi-asserted-by":"publisher","first-page":"113751","DOI":"10.1016\/j.jconrel.2025.113751","article-title":"Bioengineered bacterial extracellular vesicles for targeted delivery of an osteoclastogenesis-inhibitory peptide to alleviate osteoporosis","volume":"382","author":"Kong","year":"2025","journal-title":"J. Control Release"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.3390\/ijms20205015","article-title":"Comparing the osteogenic potentials and bone regeneration capacities of bone marrow and dental pulp mesenchymal stem cells in a rabbit calvarial bone defect model","volume":"20","author":"Lee","year":"2019","journal-title":"IJMS"},{"key":"B19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4252\/wjsc.v6.i3.288","article-title":"Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells","volume":"6","author":"Liao","year":"2014","journal-title":"World J. Stem Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/prd.12551","article-title":"The development of non\u2010resorbable bone allografts: biological background and clinical perspectives","volume":"94","author":"Miron","year":"2024","journal-title":"Periodontol. 2000"},{"key":"B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bone.2015.01.011","article-title":"Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model","volume":"74","author":"Ogata","year":"2015","journal-title":"Bone"},{"key":"B23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1600-0714.2012.01154.x","article-title":"Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition","volume":"41","author":"Patntirapong","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/jcm9061649","article-title":"Allogeneic bone marrow mesenchymal stem cell transplantation in tooth extractions sites ameliorates the incidence of osteonecrotic jaw-like lesions in zoledronic acid-treated rats","volume":"9","author":"Rodr\u00edguez-Lozano","year":"2020","journal-title":"J. Clin. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"100650","DOI":"10.1016\/j.jbo.2024.100650","article-title":"Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw","volume":"49","author":"Ruan","year":"","journal-title":"J. Bone Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00784-024-05911-z","article-title":"Medication-related osteonecrosis of the jaw: a retrospective single center study of recurrence-related factors after surgical treatment","volume":"28","author":"Ruan","year":"","journal-title":"Clin. Oral Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American association of oral and maxillofacial surgeons\u2019 position paper on medication-related osteonecrosis of the Jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1902\/jop.2000.71.8.1258","article-title":"Ability of deproteinized cancellous bovine bone to induce new bone formation","volume":"71","author":"Schwartz","year":"2000","journal-title":"J. Periodontol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"105802","DOI":"10.1016\/j.jdent.2025.105802","article-title":"Preventive effect of platelet-rich plasma\/Bio-Oss granules composite on medication-related osteonecrosis of the jaw in a rat model","volume":"158","author":"Shi","year":"2025","journal-title":"J. Dent."},{"key":"B31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1902\/jop.2007.060308","article-title":"A histologic and histomorphometric evaluation of anorganic bovine bone retrieved 9 years after a sinus augmentation procedure","volume":"78","author":"Traini","year":"2007","journal-title":"J. Periodontol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"100948","DOI":"10.1016\/j.mtbio.2024.100948","article-title":"Articular cartilage repair biomaterials: strategies and applications","volume":"24","author":"Wang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"B33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41368-022-00182-4","article-title":"Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)","volume":"14","author":"Yan","year":"2022","journal-title":"Int. J. Oral Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/0885328214521846","article-title":"Periodontal ligament versus bone marrow mesenchymal stem cells in combination with Bio-Oss scaffolds for ectopic and in situ bone formation: a comparative study in the rat","volume":"29","author":"Yu","year":"2014","journal-title":"J. Biomater. Appl."},{"key":"B35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13287-019-1277-y","article-title":"Adipose-derived stem cells prevent the onset of bisphosphonate-related osteonecrosis of the jaw through transforming growth factor \u03b2-1-mediated gingival wound healing","volume":"10","author":"Zang","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12675","DOI":"10.2147\/IJN.S482849","article-title":"Exosomes from adipose-derived mesenchymal stromal cells prevent medication-related osteonecrosis of the jaw by inhibiting macrophage M1 polarization and pyroptosis","volume":"19","author":"Zheng","year":"2024","journal-title":"IJN"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1800764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:41:40Z","timestamp":1777009300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1800764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":36,"alternative-id":["10.3389\/fbioe.2026.1800764"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2026.1800764","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1800764"}}